Iveric Bioan Astellas Companyis A Biopharmaceutical Firm Based In Parsippanynew Jerseyfocused On Developing Treatments For Retinal Diseasesestablished In 2007 And Acquired By Astellas Pharma In July 2023Iveric Bio Operates As A Wholly Owned Subsidiaryconcentrating On High Unmet Need Ophthalmic Conditionsparticularly Age Related Macular Degenerationamdthe Company Has Developed Novel Therapies For Retinal Diseaseswith Its Flagship Productizervaya Cavacincaptad Pegol Receiving Fda Approval In August 2023 For Geographic Atrophygasecondary To Amdthis Treatment Has Shown Significant Effectiveness In Reducing Ga Progression In Clinical Trialsiveric Bio S Pipeline Includes Investigational Therapies Aimed At Earlier Stages Of Amd And Other Retinal Conditionssupported By A Specialized Ophthalmology Commercial Team And Strong Relationships With Medical Institutions
No conferences found for this company.
| Company Name | Iveric Bio Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
